Synthesis and pharmacological characterization of ABT-200: a putative novel antidepressant combining potent α-2 antagonism with moderate NE uptake inhibition

Synthesis and pharmacological characterization of ABT-200: a putative novel antidepressant combining potent α-2 antagonism with moderate NE uptake inhibition Synthesis and pharmacological characterization of A-80426: A putative novel antidepressant combining α-2 antagonism with 5-HT uptake inhibition Potential Antidepressants Displayed Combined α₂-Adrenoceptor Antagonist and Monoamine Uptake Inhibitor Properties Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors Dual NK1 antagonists—serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives N-(1,2-Diphenylethyl)piperazines: A new class of dual serotonin/noradrenaline reuptake inhibitor Synthesis and antidepressant properties of novel 2-substituted 4,5-dihydro-1H-imidazole derivatives Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake Structure−Activity Studies for a Novel Series ofN-(Arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamines Possessing Dual 5-HT Uptake Inhibiting and α₂-Antagonistic Activities New Antipsychotic Agents with Serotonin and Dopamine Antagonist Properties Based on a Pyrrolo[2,1-b][1,3]benzothiazepine Structure